Document Detail


123/125I-labelled 2-iodo-L: -phenylalanine and 2-iodo-D: -phenylalanine: comparative uptake in various tumour types and biodistribution in mice.
MedLine Citation:
PMID:  16572305     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: In vitro in the R1M cell model and in vivo in the R1M tumour-bearing athymic model, both [(123)I]-2-iodo-L: -phenylalanine and [(123)I]-2-iodo-D: -phenylalanine have shown promising results as tumour diagnostic agents for SPECT. In order to compare these two amino acid analogues and to examine whether the observed characteristics could be generalised, both isomers were evaluated in various tumour models. METHODS: Transport type characterisation in vitro in A549, A2058, C6, C32, Capan2, EF43fgf4, HT29 and R1M cells with [(123)I]-2-iodo-L: -phenylalanine was performed using the method described by Shotwell et al. Subsequently, [(123)I]-2-iodo-L: -phenylalanine and [(123)I]-2-iodo-D: -phenylalanine tumour uptake and biodistribution were evaluated using dynamic planar imaging and/or dissection in A549, A2058, C6, C32, Capan2, EF43fgf4, HT29 and R1M inoculated athymic mice. Two-compartment blood modelling of the imaging results was performed. RESULTS: In vitro testing demonstrated that [(123)I]-2-iodo-L: -phenylalanine was transported in all tumour cell lines by LAT1. In all tumour models, the two amino acid analogues showed the same general biodistribution characteristics: high and specific tumour uptake and renal tracer clearance. Two-compartment modelling revealed that the D: -isomer showed a faster blood clearance together with a faster distribution to the peripheral compartment in comparison with [(123)I]-2-iodo-L: -phenylalanine. CONCLUSION: [(123)I]-2-iodo-L: -phenylalanine and its D: -isomer are promising tumour diagnostic agents for dynamic planar imaging. They showed a high and similar uptake in all tested tumours. [(123)I]-2-iodo-D: -phenylalanine showed better tracer characteristics concerning radiation dose to other organs.
Authors:
Veerle Kersemans; Bart Cornelissen; Ken Kersemans; Matthias Bauwens; Rudi A Dierckx; Bart De Spiegeleer; John Mertens; Guido Slegers
Related Documents :
8327115 - Mri of extradural spinal tumours at 0.3 t.
16421765 - Prognostic value of perfusion-weighted imaging in brain glioma: a prospective study.
9630275 - Orbital rhabdomyosarcoma--the radiological characteristics.
11668005 - False-positive magnetic resonance image in the diagnosis of small acoustic neuroma.
10597085 - Plain abdominal radiographs and abdominal ct scans for nontraumatic abdominal pain--add...
17171515 - Hemobilia after radiofrequency ablation of hepatocellular carcinoma.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2006-03-30
Journal Detail:
Title:  European journal of nuclear medicine and molecular imaging     Volume:  33     ISSN:  1619-7070     ISO Abbreviation:  Eur. J. Nucl. Med. Mol. Imaging     Publication Date:  2006 Aug 
Date Detail:
Created Date:  2006-07-25     Completed Date:  2006-11-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101140988     Medline TA:  Eur J Nucl Med Mol Imaging     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  919-27     Citation Subset:  IM    
Affiliation:
Laboratory for Radiopharmacy, Universiteit Gent, Harelbekestraat 72, B-9000, Gent, Belgium. veerle.kersemans@utoronto.ca
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Carcinoma / metabolism*
Cell Line, Tumor
Female
Humans
Isotope Labeling
Metabolic Clearance Rate
Mice
Organ Specificity
Phenylalanine / analogs & derivatives*,  diagnostic use,  pharmacokinetics
Radiopharmaceuticals / diagnostic use,  pharmacokinetics
Tissue Distribution
Tomography, Emission-Computed, Single-Photon / methods*
Chemical
Reg. No./Substance:
0/Radiopharmaceuticals; 1991-81-7/4-iodophenylalanine; 63-91-2/Phenylalanine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Role of FDG-PET and PET/CT in the diagnosis of prolonged febrile states.
Next Document:  A phase 2 study of high-activity 186Re-HEDP with autologous peripheral blood stem cell transplant in...